Leafline Labs seeks new cannabis license to support Minnesota medical patients

March 25, 2025 | Cottage Grove, Washington County, Minnesota

Thanks to Scribe from Workplace AI , all articles about Minnesota are free for you to enjoy throughout 2025!


This article was created by AI using a video recording of the meeting. It summarizes the key points discussed, but for full details and context, please refer to the video of the full meeting. Link to Full Meeting

In the heart of Cottage Grove, a significant discussion unfolded as Tiffany Newbern Johnson, Director of Government Affairs for Leafline Labs and Green Thumb Industries, addressed the City Council. With a calm confidence, she introduced her team, including Deke Fisher, the General Manager of Production, and Mark Byers from Byers Scientific, who were present to provide insights into their operations and proposals.

Leafline Labs, a cornerstone of the local economy since 2015, is one of only two licensed medical cannabis companies in Minnesota. Johnson highlighted the company’s substantial investment in the community, noting that they have poured tens of millions of dollars into their cultivation and manufacturing facilities. This commitment has not only bolstered the local economy but has also created over 240 jobs, including more than 70 positions at their Cottage Grove facility.
final logo

Before you scroll further...

Get access to the words and decisions of your elected officials for free!

Subscribe for Free

The company proudly serves over 52,000 medical cannabis patients across the state, many of whom are minors relying on specialized products for relief. Johnson emphasized the importance of their role in providing safe, high-quality cannabis products, which include tinctures, topicals, and pill capsules.

As the landscape of cannabis regulation evolves, Leafline is adapting to new laws. Johnson announced that they submitted an application for a medical cannabis combination business license under the new adult use program on February 21. She expressed optimism about the positive feedback received from the Office of Cannabis Management regarding their application. This step is crucial for Leafline to maintain its operations and continue serving Minnesota's medical community.

Family Scribe
Custom Ad
The meeting underscored the ongoing commitment of Leafline Labs to comply with state laws and regulations while reinforcing their dedication to the health and well-being of their patients. As the city navigates the complexities of cannabis legislation, the presence of such a significant local business highlights the intersection of community development and regulatory change in Cottage Grove.

Converted from Cottage Grove Planning Commission 3-24-2025 meeting on March 25, 2025
Link to Full Meeting

Comments

    View full meeting

    This article is based on a recent meeting—watch the full video and explore the complete transcript for deeper insights into the discussion.

    View full meeting

    Sponsors

    Proudly supported by sponsors who keep Minnesota articles free in 2025

    Scribe from Workplace AI
    Scribe from Workplace AI